跳至主要内容
临床试验/JPRN-UMIN000050778
JPRN-UMIN000050778招募中Unknown

JAPANESE PROSPECTIVE REAL WORLD REGISTRY OF CABOZANTINIB PLUS NIVOLUMABIN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL CELL CARCINOMA - JACUMET study

Kindai University School of Medicine0 个研究点目标入组 200 人开始时间: 2023年4月6日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Synchronous or metachronous (within 3 years) malignancies. 2)Surgery prior to initiation of cabozantinib + nivolumab combination therapy with incomplete wound healing or continued postoperative complications 3) Radiotherapy within 14 days before starting cabozantinib + nivolumab combination therapy. Must be fully recovered from radiotherapy

研究者

发起方
Kindai University School of Medicine

相似试验